{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:00:24Z","timestamp":1761858024626,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.otc.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T02:40:21Z","timestamp":1623206421000},"page":"709-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice"],"prefix":"10.1016","volume":"54","author":[{"given":"Lauren T.","family":"Roland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5907-3421","authenticated-orcid":false,"given":"Joshua M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.otc.2021.04.002_bib1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/lary.25180","article-title":"Cost of adult chronic rhinosinusitis: a systematic review","volume":"125","author":"Smith","year":"2015","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s40629-017-0048-5","article-title":"Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities","volume":"27","author":"Koennecke","year":"2018","journal-title":"Allergo J Int"},{"issue":"4","key":"10.1016\/j.otc.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2500\/ajra.2017.31.4443","article-title":"Central compartment atopic disease","volume":"31","author":"DelGaudio","year":"2017","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.otc.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"issue":"suppl 1","key":"10.1016\/j.otc.2021.04.002_bib6","first-page":"S1","article-title":"Targeted molecular therapies in allergy and rhinology","volume":"164","author":"Damask","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0194599820939964","article-title":"Role of biologics in chronic rhinosinusitis with nasal polyposis: state of the art review","volume":"164","author":"Kim","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib8","first-page":"E26","article-title":"Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2020","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.otc.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.anai.2019.07.004","article-title":"A\u00a0call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps","volume":"123","author":"Codispoti","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.otc.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaip.2020.02.023","article-title":"Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics. a national institute of allergy and infectious diseases workshop","volume":"8","author":"Naclerio","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.otc.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.otc.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.otc.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/alr.22633","article-title":"Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop","volume":"10","author":"Roland","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.otc.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"1701782","DOI":"10.1183\/13993003.01782-2017","article-title":"Care pathways for the selection of a biologic in severe asthma","volume":"50","author":"Bousquet","year":"2017","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.otc.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.otc.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jaip.2020.06.029","article-title":"The treatment paradigm of chronic rhinosinusitis with nasal polyps in the COVD-19 Era","volume":"8","author":"Roland","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaci.2020.04.030","article-title":"Perspective: COVID-19, implications of nasal diseases and consequences for their management","volume":"146","author":"Jian","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"e13475","DOI":"10.1111\/dth.13475","article-title":"Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration","volume":"33","author":"Damiani","year":"2020","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.otc.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/alr.22163","article-title":"Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study","volume":"8","author":"Corrado","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"10.1016\/j.otc.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/lary.29137","article-title":"Elevated Urine Leukotriene E4 is associated with worse objective markers in nasal polyposis patients","volume":"131","author":"Choby","year":"2020","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.otc.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamaoto.2020.1453","article-title":"Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review","volume":"146","author":"Grayson","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.otc.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2021.04.002_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/alr.22473","article-title":"The role of biologics in chronic rhinosinusitis: a systematic review","volume":"10","author":"Iqbal","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/lio2.236","article-title":"The relationship between allergy and chronic rhinosinusitis","volume":"4","author":"Marcus","year":"2019","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alr.22036","article-title":"Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"8","author":"Adappa","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2021.04.002_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:52:30Z","timestamp":1758466350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666521000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0030666521000505"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2021.04.002","relation":{},"ISSN":["0030-6665"],"issn-type":[{"type":"print","value":"0030-6665"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}